Atlas Trials

18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients

Clinical trial NCT06655545 · COMPLETED

Trial details

NCT number
NCT06655545
Sponsor
Fudan University
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2023-07-15
Primary completion
2024-10-15
Enrollment
473

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.